The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer [Retraction]
Li X, Song C, Huang G, Sun S, Qiao J, Zhao J, Zhao Z, Li M. The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer. OncoTargets and Therapy. 2017;10:1735–1742.The authors have advised us of concerns about the specificity of the primary antib...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2017-05-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | https://www.dovepress.com/retraction-the-coexpression-of-ephb4-and-ephrinb2-is-associated-w-peer-reviewed-article-OTT |